Xeris Biopharma Holdings Inc
XERS·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$8.96
Today
+3.3%
YTD
+14.7%
About
Xeris Pharmaceuticals Inc is an American specialty pharmaceutical company that provides patients in the United States with ready-to-use, liquid-stable injectables. Established in 2005, the firm is based in Chicago, Illinois, and trades on the NASDAQ GS with the ticker XERS. Follow this instrument on eToro to find the latest XERS price chart updates.
Price chart
Closing price history for XERS (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)127.33
P/S (TTM)4.71
P/B (TTM)110.61
Market cap$1.44B
Cap tierSmall-cap
Industry avg P/E-6.24
Profitability
Gross margin82.45%
EBIT margin11.40%
Net margin2.69%
ROE-617.16%
ROA3.39%
Earnings & Revenue
Revenue (TTM)$314.85M
Revenue growth (1Y)+41.5%
EPS (TTM)$0.07
Free cash flow$47.52M
Total debt$258.55M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.21
Employees435
Next earnings5 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.